Hemin toxicity in a human epithelioid sarcoma cell line

被引:0
|
作者
Braverman, S [1 ]
Helson, C [1 ]
Helson, L [1 ]
机构
[1] ST AGNES HOSP, WHITE PLAINS, NY 10605 USA
关键词
hemin; protoporphyrin IX; epithelioid sarcoma; deferoxamine; lipid peroxidation;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The major cytotoxic component of hemin was identified as metal free protoporphyrin IX in an epithelioid sarcoma cell line (VA-ES-BJ) and a glioblastoma cell line (U-373 MG) by exposing the cell lines to the iron chelator deferoxamine, tin-protoporphylin IX, and protoporphyrin IX. The contribution of lipid peroxidation and free radical generation to toxicity was examined ruing DL-buthionine-[S,R]-sulfoximine (BSO), and 21-aminosteroid (lazaroid, U74500A). Hemin caused significantly greater toxicity in VA-ES-BJ than in U-373 MG. While exogenous PpIX was more toxic than hemin in both cell lines, this toxicity was not due to iron depletion following intracellular heme formation since ferric citrate did not reverse PpIX toxicity. Pre-treatment with BSO enhanced hemin toxicity in the VA-ES-BJ cell line but not in U-373 MG, suggesting different modes of toxicity in the two cell lines. Exposure to lazaroid protected only VA-ES-BJ from protoporphyrin-induced toxicity implicating a specific sensitivity to lipid peroxidation and/or free radical generation by this cell line. These characteristics of the VA-ES-BJ cell line distinguish it fi om the glioblastoma and emphasize its utility for exploring cytotoxic effects of hemin and its precursors.
引用
收藏
页码:1963 / 1967
页数:5
相关论文
共 50 条
  • [1] CHARACTERIZATION AND CHEMOSENSITIVITY OF A HUMAN EPITHELIOID SARCOMA CELL-LINE (SARCCR-2)
    ROCHE, H
    JULIA, AM
    JOZAN, S
    MULLER, C
    DASTUGUE, N
    ARQUIER, MA
    MARQUES, B
    LAURENT, G
    CANAL, P
    INTERNATIONAL JOURNAL OF CANCER, 1993, 54 (04) : 663 - 668
  • [2] INTERCLONAL HETEROGENEITY IN A HUMAN EPITHELIOID-SARCOMA CELL-LINE (GRU-1)
    ENGERS, R
    GERHARZ, CD
    MOLL, R
    POHL, A
    SARBIA, M
    GABBERT, HE
    INTERNATIONAL JOURNAL OF CANCER, 1994, 59 (04) : 548 - 553
  • [3] VA-ES-BJ - AN EPITHELIOID SARCOMA CELL-LINE
    HELSON, C
    MELAMED, M
    BRAVERMAN, S
    TRAGANOS, F
    PRETI, RA
    HELSON, L
    INTERNATIONAL JOURNAL OF ONCOLOGY, 1995, 7 (01) : 51 - 56
  • [4] ULTRASTRUCTURAL, IMMUNOCYTOCHEMICAL, AND CYTOGENETIC CHARACTERIZATION OF A HUMAN EPITHELIOID SARCOMA CELL-LINE (RM-HS1)
    REEVES, BR
    FISHER, C
    SMITH, S
    COURTENAY, VD
    ROBERTSON, D
    JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1987, 78 (01) : 7 - 18
  • [5] MORPHOLOGICAL CHARACTERIZATION OF A NEW HUMAN EPITHELIOID SARCOMA CELL-LINE, ES020488, INVITRO AND INVIVO
    SONOBE, H
    FURIHATA, M
    IWATA, J
    OKA, T
    OHTSUKI, Y
    HAMASATO, S
    FUJIMOTO, S
    VIRCHOWS ARCHIV B-CELL PATHOLOGY INCLUDING MOLECULAR PATHOLOGY, 1993, 63 (04) : 219 - 225
  • [6] RADIOSENSITIVITY AND CHARACTERIZATION OF A NEWLY ESTABLISHED CELL-LINE FROM AN EPITHELIOID SARCOMA
    KELLAND, LR
    BINGLE, L
    BRITISH JOURNAL OF CANCER, 1988, 58 (03) : 322 - 325
  • [7] Growth inhibition in clonal subpopulations of a human epithelioid sarcoma cell line by retinoic acid and tumour necrosis factor alpha
    Engers, R
    vanRoy, F
    Heymer, T
    Ramp, U
    Moll, R
    Dienst, M
    Friebe, U
    Pohl, A
    Gabbert, HE
    Gerharz, CD
    BRITISH JOURNAL OF CANCER, 1996, 73 (04) : 491 - 498
  • [8] Establishment and characterization of an epithelioid sarcoma cell line with an autocrine response to interleukin-6
    H. Kusakabe
    Shoko Sakatani
    Kohji Yonebayashi
    Kimihiro Kiyokane
    Archives of Dermatological Research, 1997, 289 : 224 - 233
  • [9] Establishment and characterization of an epithelioid sarcoma cell line with an autocrine response to interleukin-6
    Kusakabe, H
    Sakatani, S
    Yonebayashi, K
    Kiyokane, K
    ARCHIVES OF DERMATOLOGICAL RESEARCH, 1997, 289 (04) : 224 - 233
  • [10] IMMUNOLOGICAL MARKERS AND PRODUCTS OF A HUMAN EPITHELIOID CELL-LINE
    MOLDOVEANU, Z
    WHITEHEAD, RH
    IWASE, T
    MORO, I
    MESTECKY, J
    JOURNAL OF IMMUNOLOGY, 1993, 150 (08): : A36 - A36